New combo treatment matches standard for esophageal cancer survival
Knowledge-focused
Completed
This study looked at 200 people with advanced esophageal cancer to see if a newer treatment (immunotherapy plus chemotherapy) works as well as the standard treatment (chemotherapy plus radiation) before surgery. Both treatments led to similar long-term survival rates. The newer t…
Phase: NA • Sponsor: Yongtao Han • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC